Cargando…

Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer

BACKGROUND: Although TP53 and SPOP are frequently mutated in metastatic prostate cancer (PCa), their prognostic value is ambiguous, and large sample studies are lacking, especially when they co-occur with other genetic alterations. METHODS: Genomic data and patients’ clinical characteristics in PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Lai, Yiming, Peng, Shengmeng, Tang, Chen, Chen, Yongming, Li, Lingfeng, Huang, Hai, Guo, Zhenghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471084/ https://www.ncbi.nlm.nih.gov/pubmed/36119488 http://dx.doi.org/10.3389/fonc.2022.957404

Ejemplares similares

Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study
por: Chen, Yongming, et al.
Publicado: (2022)

TP53, SPOP and PIK3CA Genes Status in Prostate Cancer
por: Al Zoubi, Mazhar Salim, et al.
Publicado: (2020)

The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis
por: Ma, Jinlu, et al.
Publicado: (2021)

SPOP the mutation
por: Rider, Leah, et al.
Publicado: (2015)

Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
por: Zhang, Wensheng, et al.
Publicado: (2022)

Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
por: Li, Yanong, et al.
Publicado: (2021)

Impact of Low-Burden TP53 Mutations in the Management of CLL
por: Lazarian, Gregory, et al.
Publicado: (2022)

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
por: Catherwood, Mark A., et al.
Publicado: (2022)

SPOP mutation leads to genomic instability in prostate cancer
por: Boysen, Gunther, et al.
Publicado: (2015)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis
por: Jin, Xiaofeng, et al.
Publicado: (2021)

TP53 structural variants in metastatic prostatic carcinoma
por: Sirohi, Deepika, et al.
Publicado: (2019)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
por: Molica, Matteo, et al.
Publicado: (2021)

Current insights into the regulation of programmed cell death by TP53 mutation in cancer
por: Su, Yali, et al.
Publicado: (2022)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma
por: Saghaeiannejad Esfahani, Hoda, et al.
Publicado: (2021)

Corrigendum: Current insights into the regulation of programmed cell death by TP53 mutation in cancer
por: Su, Yali, et al.
Publicado: (2022)

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer
por: Sun, Kun, et al.
Publicado: (2023)

Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
por: Gao, Jing, et al.
Publicado: (2021)

H2AFZ Is a Prognostic Biomarker Correlated to TP53 Mutation and Immune Infiltration in Hepatocellular Carcinoma
por: Dong, Mingwei, et al.
Publicado: (2021)

Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
por: Ding, Guanxiong, et al.
Publicado: (2020)

Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
por: Soussi, Thierry, et al.
Publicado: (2022)

Case Report: A novel TP53 mutation in a patient with quadruple wild-type gastrointestinal stromal tumor
por: Chen, Yuhong, et al.
Publicado: (2023)

Identification of SPOP related metabolic pathways in prostate cancer
por: Yan, Min, et al.
Publicado: (2017)

Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
por: Jovanović, Katarina K., et al.
Publicado: (2019)

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
por: Boyarskikh, Ulyana A., et al.
Publicado: (2020)

Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report
por: Colombo, Carla, et al.
Publicado: (2022)

STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
por: Hu, Shanshan, et al.
Publicado: (2020)

SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG
por: Shoag, Jonathan, et al.
Publicado: (2017)

Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer
por: Jin, Xiaofeng, et al.
Publicado: (2017)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

TP53 Status is Associated with Thrombospondin1 Expression In vitro
por: Alvarez Secord, Angeles, et al.
Publicado: (2013)

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer
por: Hsu, Hung-Chih, et al.
Publicado: (2019)

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
por: Liu, Surui, et al.
Publicado: (2022)

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer
por: Lin, Chunhao, et al.
Publicado: (2019)

LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
por: Wang, Longrong, et al.
Publicado: (2021)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

TP53 gene implications in prostate cancer evolution: potential role in tumor classification
por: Schitcu, Vlad Horia, et al.
Publicado: (2023)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ka5c4jn9v3idbmeotgccljh8qd